Mineralys Therapeutics (MLYS) Institutional Ownership $15.55 -0.48 (-2.99%) Closing price 06/11/2025 04:00 PM EasternExtended Trading$15.55 0.00 (0.00%) As of 03:59 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Institutional Ownership Changes (13F Filings) for Mineralys Therapeutics (NASDAQ:MLYS)CurrentInstitutional OwnershipPercentage84.46%Number ofInstitutional Buyers(last 12 months)74TotalInstitutional Inflows(last 12 months)$188.54MNumber ofInstitutional Sellers(last 12 months)16TotalInstitutional Outflows(last 12 months)$28.74M Get MLYS Insider Trade Alerts Want to know when executives and insiders are buying or selling Mineralys Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data MLYS Institutional Buying and Selling by Quarter Mineralys Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails5/29/2025 Rhumbline Advisers39,361$625K0.0%-2.9%0.060% 5/28/2025 Strs Ohio22,600$359K0.0%N/A0.035% 5/16/2025 Woodline Partners LP47,662$757K0.0%N/A0.073% 5/16/2025 Goldman Sachs Group Inc.298,395$4.74M0.0%+166.6%0.460% 5/16/2025 Parkman Healthcare Partners LLC293,928$4.67M0.6%N/A0.453% 5/16/2025 Polar Asset Management Partners Inc.20,130$320K0.0%-79.7%0.031% 5/16/2025 MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.17,085$271K0.0%+4.3%0.026% 5/16/2025 Cinctive Capital Management LP14,219$226K0.0%N/A0.022% 5/16/2025 AQR Capital Management LLC34,615$550K0.0%N/A0.053% 5/16/2025 ADAR1 Capital Management LLC263,425$4.18M0.8%-68.7%0.406% Get the Latest News and Ratings for MLYS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Mineralys Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/15/2025 RA Capital Management L.P.6,147,280$97.62M1.6%+26.7%9.475% 5/15/2025 Nantahala Capital Management LLC787,740$12.51M0.5%+24.5%1.214% 5/15/2025 Quarry LP7,000$111K0.0%N/A0.011% 5/15/2025 DAFNA Capital Management LLC309,200$4.91M1.4%+111.1%0.477% 5/15/2025 Velan Capital Investment Management LP150,600$2.39M2.5%N/A0.232% 5/15/2025 Canada Pension Plan Investment Board279,500$4.44M0.0%N/A0.431% 5/15/2025 Trexquant Investment LP126,535$2.01M0.0%N/A0.195% 5/14/2025 22NW LP461,344$7.33M5.6%N/A0.711% 5/14/2025 Pale Fire Capital SE399,498$6.34M0.8%+191.8%0.616% 5/14/2025 AlphaQuest LLC15,925$253K0.0%+4.6%0.025% 5/14/2025 Monashee Investment Management LLC112,457$1.79M0.2%N/A0.173% 5/14/2025 Candriam S.C.A.882,833$14.02M0.1%+189.2%1.361% 5/14/2025 Erste Asset Management GmbH45,000$660K0.0%N/A0.069% 5/14/2025 Wellington Management Group LLP121,557$1.93M0.0%+32.8%0.187% 5/13/2025 SR One Capital Management LP3,127,933$49.67M12.8%+55.1%4.821% 5/13/2025 American Century Companies Inc.823,616$13.08M0.0%-2.9%1.270% 5/13/2025 Informed Momentum Co LLC164,273$2.61M0.5%N/A0.253% 5/12/2025 Nuveen LLC67,877$1.08M0.0%N/A0.105% 5/12/2025 Virtu Financial LLC25,203$400K0.0%N/A0.039% 5/12/2025 Invesco Ltd.308,310$4.90M0.0%N/A0.475% 5/9/2025 Deutsche Bank AG296,015$4.70M0.0%+1,007.3%0.456% 5/9/2025 Charles Schwab Investment Management Inc.270,175$4.29M0.0%+25.7%0.416% 5/9/2025 Vanguard Group Inc.2,035,506$32.32M0.0%+42.1%3.138% 5/8/2025 XTX Topco Ltd13,785$219K0.0%N/A0.021% 5/8/2025 Federated Hermes Inc.11,951$190K0.0%-23.0%0.018% 5/5/2025 Jennison Associates LLC1,979,033$31.43M0.0%+82.9%3.050% 5/2/2025 SBI Securities Co. Ltd.1,590$25K0.0%+297.5%0.002% 5/1/2025 CWM LLC8,342$132K0.0%+59.3%0.013% 4/30/2025 Alps Advisors Inc.34,664$550K0.0%-13.9%0.053% 4/29/2025 Bank of New York Mellon Corp67,868$1.08M0.0%+3.9%0.105% Get Ready for Elon Musk’s BIGGEST Comeback Yet (Ad)Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… The "experts" said Elon was finished and Tesla was headed for bankruptcy. Now they're saying the same thing, but Jeff has uncovered Tesla's next breakthrough. Click here to see why Tesla's about to prove everyone wrong... again.4/8/2025 Rhumbline Advisers39,361$625K0.0%-2.9%0.063% 4/7/2025 GAMMA Investing LLC8,829$140K0.0%+9,602.2%0.014% 3/24/2025 Wellington Management Group LLP91,529$1.13M0.0%+43.0%0.146% 2/25/2025 Polar Asset Management Partners Inc.99,100$1.22M0.0%+144.7%0.199% 2/17/2025 Tema Etfs LLC89,529$1.10M0.5%N/A0.180% 2/17/2025 Stempoint Capital LP400,101$4.93M1.2%N/A0.804% 2/17/2025 Sphera Funds Management LTD.190,672$2.35M0.4%-30.0%0.383% 2/17/2025 Polar Asset Management Partners Inc.99,100$1.22M0.0%+144.7%0.199% 2/17/2025 ProShare Advisors LLC10,405$128K0.0%N/A0.021% 2/17/2025 OCONNOR A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS LLC28,068$346K0.0%-9.7%0.056% 2/17/2025 Orbimed Advisors LLC1,611,637$19.84M0.4%-19.5%3.238% 2/17/2025 Millennium Management LLC1,101,674$13.56M0.0%+1,015.8%2.214% 2/17/2025 Letko Brosseau & Associates Inc.16,500$203K0.0%+44.7%0.033% 2/17/2025 Integral Health Asset Management LLC875,000$10.77M0.9%+145.8%1.758% 2/17/2025 Deutsche Bank AG26,732$329K0.0%+62.3%0.054% 2/17/2025 Balyasny Asset Management L.P.17,786$219K0.0%N/A0.036% 2/17/2025 Bank of America Corp DE107,703$1.33M0.0%+12.0%0.216% 2/17/2025 BNP Paribas Financial Markets3,895$48K0.0%N/A0.008% 2/17/2025 Adams Street Partners LLC1,129,807$13.91M12.3%-26.3%2.270% 2/14/2025 Caligan Partners LP1,011,155$12.45M3.3%+3.1%2.032% 2/14/2025 Northern Trust Corp246,113$3.03M0.0%+0.7%0.495% 2/14/2025 Boothbay Fund Management LLC650,023$8.00M0.2%+7.3%1.306% 2/14/2025 Virtus ETF Advisers LLC5,842$72K0.0%-19.6%0.012% 2/14/2025 Price T Rowe Associates Inc. MD11,715$145K0.0%N/A0.024% 2/14/2025 Dimensional Fund Advisors LP16,412$202K0.0%N/A0.033% 2/13/2025 Barclays PLC46,396$571K0.0%+21.4%0.093% 2/13/2025 Renaissance Technologies LLC119,500$1.47M0.0%+15.1%0.240% 2/13/2025 ADAR1 Capital Management LLC841,541$10.36M2.1%+15.4%1.691% 2/13/2025 Federated Hermes Inc.15,516$191K0.0%-7.9%0.031% 2/13/2025 Wells Fargo & Company MN23,714$292K0.0%+19.1%0.048% 2/12/2025 Wellington Management Group LLP91,529$1.13M0.0%+43.0%0.184% 2/12/2025 NEOS Investment Management LLC89,529$1.10M0.0%-27.5%0.180% 2/12/2025 JPMorgan Chase & Co.503,590$6.20M0.0%+2,251.5%1.012% 2/11/2025 EntryPoint Capital LLC12,487$154K0.1%N/A0.025% 2/11/2025 Prudential Financial Inc.125,650$1.55M0.0%+85.7%0.252% 2/11/2025 Corebridge Financial Inc.14,197$175K0.0%-7.0%0.029% 2/11/2025 Vanguard Group Inc.1,432,042$17.63M0.0%+5.0%2.877% 2/11/2025 American Century Companies Inc.848,630$10.45M0.0%-8.9%1.705% 2/7/2025 AlphaQuest LLC15,222$187K0.0%+2,637.8%0.031% 2/7/2025 Candriam S.C.A.305,272$3.76M0.0%N/A0.613% 2/6/2025 Proficio Capital Partners LLC23,192$285K0.0%N/A0.047% 2/6/2025 Charles Schwab Investment Management Inc.214,906$2.65M0.0%+0.6%0.432% 2/5/2025 Proficio Capital Partners LLC23,192$285K0.0%N/A0.047% 2/4/2025 Bank of New York Mellon Corp65,318$804K0.0%+2.7%0.131% 1/24/2025 Jennison Associates LLC1,082,006$13.32M0.0%+55.4%2.174% 1/24/2025 China Universal Asset Management Co. Ltd.10,553$130K0.0%+10.3%0.021% 1/17/2025 SG Americas Securities LLC19,961$246K0.0%+119.0%0.040% 11/27/2024 Franklin Resources Inc.1,745,513$21.14M0.0%+17.7%3.507% 11/19/2024 Barclays PLC38,218$463K0.0%+281.8%0.077% 11/16/2024 Geode Capital Management LLC620,853$7.52M0.0%+6.6%1.247% The Trump Dump is starting; Get out of stocks now? (Ad)The first 365 days of the Trump presidency… Will be the best time to get rich in American history.If I’m right about this (like I was before) a modest $900 investment could grow to a life-changing a11/15/2024 Barclays PLC38,218$463K0.0%+281.8%0.077% 11/15/2024 Jane Street Group LLC15,855$192K0.0%-30.4%0.032% 11/15/2024 Wellington Management Group LLP63,998$775K0.0%N/A0.129% 11/15/2024 Sphera Funds Management LTD.272,472$3.30M0.5%-38.5%0.547% 11/15/2024 State Street Corp483,766$5.86M0.0%+4.0%0.972% 11/15/2024 Polar Asset Management Partners Inc.40,500$490K0.0%N/A0.081% 11/15/2024 Ikarian Capital LLC180,000$2.18M0.3%N/A0.362% 11/14/2024 Bellevue Group AG16,499$200K0.0%-5.7%0.033% 11/14/2024 Caligan Partners LP981,155$11.88M3.8%+31.6%1.973% 11/14/2024 PDT Partners LLC12,238$148K0.0%N/A0.025% (Data available from 1/1/2016 forward) MLYS Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of MLYS shares? During the previous two years, 105 institutional investors and hedge funds held shares of Mineralys Therapeutics. The most heavily invested institutionals were RA Capital Management L.P. ($97.62M), Catalys Pacific LLC ($79.07M), SR One Capital Management LP ($49.67M), Vanguard Group Inc. ($32.32M), Jennison Associates LLC ($31.43M), Franklin Resources Inc. ($21.14M), and Orbimed Advisors LLC ($19.84M).Learn more on MLYS's institutional investors. What percentage of Mineralys Therapeutics stock is owned by institutional investors? 84.46% of Mineralys Therapeutics stock is owned by institutional investors. Learn more on MLYS's institutional investor holdings. Which institutional investors have been buying Mineralys Therapeutics stock? Of the 93 institutional investors that purchased Mineralys Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: Catalys Pacific LLC ($9.19M), RA Capital Management L.P. ($2.97M), Braidwell LP ($1.47M), SR One Capital Management LP ($1.33M), Jennison Associates LLC ($1.30M), Millennium Management LLC ($1.00M), and Candriam S.C.A. ($882.83K). How much institutional buying is happening at Mineralys Therapeutics? Institutional investors have bought a total of 28,321,546 shares in the last 24 months. This purchase volume represents approximately $334.29M in transactions. Which Mineralys Therapeutics major shareholders have been selling company stock? Of the 25 institutional investors that sold Mineralys Therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: Adams Street Partners LLC ($590.63K), ADAR1 Capital Management LLC ($578.12K), Orbimed Advisors LLC ($391.30K), Sphera Funds Management LTD. ($252.08K), Sectoral Asset Management Inc. ($235.15K), American Century Companies Inc. ($108.03K), and Blue Owl Capital Holdings LP ($90.74K). How much institutional selling is happening at Mineralys Therapeutics? Institutional investors have sold a total of 2,524,598 shares in the last 24 months. This volume of shares sold represents approximately $32.68M in transactions. Related Companies MRUS Institutional Ownership RYTM Institutional Ownership AKRO Institutional Ownership RNA Institutional Ownership PTCT Institutional Ownership CYTK Institutional Ownership SRPT Institutional Ownership KRYS Institutional Ownership ACAD Institutional Ownership SWTX Institutional Ownership This page (NASDAQ:MLYS) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredNew Rule Hits in July — The Smart Money Already MovedA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredGold is soaring. Here’s how to get paid from itGold just broke through $3,300… And while the headlines shout about price targets, something even more powe...Investors Alley | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredTrump Makes Major Crypto AnnouncementPay close attention to what I'm about to share… Most investors think Trump's pro-crypto policies will lift ...Crypto 101 Media | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredMarch 16th -- America’s most important day?50-Year Legend: Here's The Day Stocks Likely Crash Legendary quant analyst Marc Chaikin says in 50 years on...Chaikin Analytics | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mineralys Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Mineralys Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy MLYS Stock Free MLYS Stock Alerts